Search Results
Insurtech deals on the up, but total funding drops
Willis Towers Watson ascribes funding drop to fewer “high dollar” transactions
Activist ups pressure on Scor over Covea deal
Scor still rejects approach by largest shareholder
Vaudoise bucks European trend and posts non-life profits
Swiss group non-life premiums by 3.8% in the first half of the year
Finding the goal in insurtech - part one: the investors
Strategies for capitalising on new insurance technologies are as varied as the technologies themselves. In part one of this series of interviews, Cintia Cheong talks to insurtech investors about the most promising areas for tech development, and how they are making their investments
Still room for SFCR improvement, BaFin tells industry
German regulator says improvements are evident in second year of reporting, though
Marsh & McLennan swoops for JLT
The mega deal will combine two of the largest insurance and reinsurance broking groups
Chinese insurers' C-Ross compliance pays off
But firms are still exposed to risky investments
AMP took life premiums from dead customers, Royal Commission hears
Inquiry had summoned Australian insurer for a second time
Australian health industry gets new prudential standards
Regulator issues rules on governance, board membership and audit
China Re to acquire speciality insurer Chaucer
The Hanover sells out in $950m deal